Treating Diabetes with
Snail Venom?
UNH researchers find potential for drug in unlikely source
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POPULAR AMONG SEASHELL COLLECTORS, THE MOTTLED SHELL OF THE VENOMOUS CONE
SNAIL HOUSES A POTENTIAL TREATMENT FOR DIABETES. CREDIT: WIKIPEDIA COMMONS.

UNH researchers have found a potential treatment for diabetes from an unlikely source:
Snail venom.

With a smooth, mottled shell popular among seashell collectors, the cone snail releases
a potent insulin-like venom that can paralyze its prey. UNH chemical
engineering researchers Harish Vashisth and Biswajit Gorai have found that variants of
this venom, known as cone snail insulin (Con-Ins), could offer future possibilities for
developing new fast-acting drugs to help treat diabetes.

“Diabetes is rising at an alarming rate, and it’s become
increasingly important to find new alternatives for
developing effective and budget-friendly drugs for
patients with the disease.”
“Diabetes is rising at an alarming rate, and it’s become increasingly important to find
new alternatives for developing effective and budget-friendly drugs for patients with the
disease,” says Vashisth, associate professor of chemical engineering. “Our work found
that the modeled Con-Ins variants, or analogs, bind even better to receptors in the body
than the human hormone and may work faster, which could make them a favorable
option for stabilizing blood sugar levels and a potential for new therapeutics.”
In their study, recently published in the journal Proteins: Structure, Function, and
Bioinformatics, the researchers looked closely at the cone snail venom, which induces a
hypoglycemic reaction that lowers blood sugar levels. Unlike insulin made in the body,
the venom’s peptide sequence, which allows it to bind to human insulin receptors, is
much shorter. To test whether it would still bind effectively, the researchers used
sequences of the insulin-like peptides in the venom of the cone snail C. geographus as
a template to model six different Con-Ins analogs. The newly created variants were
made up of much shorter peptide chains than human insulin.
To study the stability and variability of the new Con-Ins structures, Vashisth and Gorai
conducted multiple independent computer simulations of each Con-Ins variant complex
with human insulin receptor in a near-physiological environment (accounting for water
solvent, salinity of solution, temperature and pressure). They found that each insulin
complex remained stable during the simulations and the designed peptides bound
strongly – even better than the naturally occurring human insulin hormone. The
interactions were then compared with the human insulin receptor, and it was determined
that each Con-Ins variant exhibits few feasible residue substitutions in human insulin.
“While more studies are needed, our research shows that despite the shorter peptide
sequences, the cone snail venom could be a viable substitute and we are hopeful it will
motivate future designs for new fast-acting drug options,” says Gorai, postdoctoral
research associate and lead author.
The insulin-like venom released by certain cone snails can be highly dangerous,
causing a hypoglycemic shock that immobilizes fish and potential prey. C.
geographus has the most toxic sting known among the species and there have been
reports of human fatalities, especially to unsuspected divers who are not aware of the
snail’s venom.
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